Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Transfusion|February 10, 2011
Nonleukemic myeloid dendritic cells obtained from autologous stem cell products elicit antileukemia responses in patients with acute myeloid leukemiaJuana Serrano-López, Joaquin Sanchez-Garcia, Josefina Serrano, et al.
Leukemia Research|March 27, 2007
Epigenetic regulation of PRAME gene in chronic myeloid leukemiaJose Roman-Gomez, Antonio Jimenez-Velasco, Xabier Agirre, et al.
Haematologica|February 14, 2007
Epigenetic regulation of human cancer/testis antigen gene, HAGE, in chronic myeloid leukemiaJose Roman-Gomez, Antonio Jimenez-Velasco, Xabier Agirre, et al.
European Journal of Cancer (Oxford, England : 1990)|November 23, 2007
WNT5A, a putative tumour suppressor of lymphoid malignancies, is inactivated by aberrant methylation in acute lymphoblastic leukaemiaJose Roman-Gomez, Antonio Jimenez-Velasco, Lucia Cordeu, et al.
Optics Express|May 3, 2018
Widely-tunable, narrow-linewidth III-V/silicon hybrid external-cavity laser for coherent communicationHang Guan, Ari Novack, Tal Galfsky, et al.
Cancer Science|June 14, 2008
Methylation status of Wnt signaling pathway genes affects the clinical outcome of Philadelphia-positive acute lymphoblastic leukemiaVanesa Martin, Xabier Agirre, Antonio Jiménez-Velasco, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 18, 2006
CpG island methylator phenotype redefines the prognostic effect of t(12;21) in childhood acute lymphoblastic leukemiaJose Roman-Gomez, Antonio Jimenez-Velasco, Xabier Agirre, et al.
Journal of Neurochemistry|May 22, 2009
Tau--an inhibitor of deacetylase HDAC6 functionMar Perez, Ismael Santa-Maria, Elena Gomez de Barreda, et al.
European Journal of Cancer (Oxford, England : 1990)|May 1, 2009
Epigenetic down-regulation of BIM expression is associated with reduced optimal responses to imatinib treatment in chronic myeloid leukaemiaEdurne San José-Eneriz, Xabier Agirre, Antonio Jiménez-Velasco, et al.
Blood|June 24, 2010
Reversion of epigenetically mediated BIM silencing overcomes chemoresistance in Burkitt lymphomaJose A Richter-Larrea, Eloy F Robles, Vicente Fresquet, et al.
Pageof 4